基本信息
views: 129
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
He is a member of the Pharmacology and Molecular Mechanisms Group of the EORTC (European Organisation for Research and Cancer Treatment) from 1988 to now. The main fields of interest where the research is carried out are: a)Clinica l pharmacology, Phase I and II studies of new drugs b)Drug analysis, pharmacokinetics and pharmacodynamics studies c)Development of innovative methods for the measurement of anti-tumour drugs (HPLC-u MS/MS-MALDI imaging mass spectrometers). d)Clinical studies in GCP and GLP e)Pharmacokinetics, toxicokinetics and metabolic studies o f new drugs in animal models f)Pharmacokinetic drug interaction studies He is the author or co-author of over a hundred scientific publications on clinical and preclinical antitumour chemotherapy topics.
Research Interests
Papers共 320 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Pharmaceuticsno. 3 (2024): 387
Michela Chiappa,Alessandra Decio, Luca Guarrera, Ilaria Mengoli, Anju Karki, Divora Yemane,Carmen Ghilardi, Eugenio Scanziani, Simone Canesi, Maria C. Barbera,Ilaria Craparotta, Marco Bolis,
CELL DEATH & DISEASEno. 7 (2024): 521-521
Greta Pessino,Leonardo Lonati,Claudia Scotti, Silvia Calandra, Ornella Cazzalini, Ombretta Iaria, Andrea Previtali,Giorgio Baiocco, Paola Perucca, Anna Tricarico, Martina Vetro,Lucia Anna Stivala,
Heliyonno. 15 (2024): e35789-e35789
INTERNATIONAL JOURNAL OF NANOMEDICINE (2024): 429-440
Journal of clinical oncologyno. 8 (2024): 915-926
Cristina Matteo, Isabella Orienti,Adriana Eramo, Ann Zeuner, Mariella Ferrari,Alice Passoni, Renzo Bagnati,Marianna Ponzo,Ezia Bello,Massimo Zucchetti,Roberta Frapolli
crossref(2024)
Bloodno. Supplement 1 (2023): 5879-5879
crossref(2023)
HemaSphereno. 6 (2023): e893-e893
Load More
Author Statistics
#Papers: 320
#Citation: 7915
H-Index: 43
G-Index: 75
Sociability: 7
Diversity: 1
Activity: 1
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn